Using a modified Delphi process to establish clinical consensus for the diagnosis, risk assessment and abatacept treatment in patients with aggressive rheumatoid arthritis

We aimed to formulate consensus statements for the identification of patients with rheumatoid arthritis (RA) who may benefit most from abatacept treatment, in order to clear up points related to its use in rheumatology.

Data di pubblicazione: 2017
Titolo: Using a modified Delphi process to establish clinical consensus for the diagnosis, risk assessment and abatacept treatment in patients with aggressive rheumatoid arthritis
Autori: Caporali, Roberto; Carletto, Antonio; Conti, Fabrizio; D'Angelo, Salvatore; Foti, Rosario; Gremese, Elisa; Govoni, Marcello; Iannone, Florenzo; Pellerito, Raffaele; Sinigaglia, Luigi
Rivista: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Parole Chiave: diagnosis, risk assessment, abatacept treatment,aggressive rheumatoid arthritis
Abstract: We aimed to formulate consensus statements for the identification of patients with rheumatoid arthritis (RA) who may benefit most from abatacept treatment, in order to clear up points related to its use in rheumatology.
Digital Object Identifier (DOI): NA
Handle: http://hdl.handle.net/11392/2368936
Appare nelle tipologie:03.1 Articolo su rivista

File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2022